Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

OROXID oral solution for treating periodontitis

Official title: Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Periodontitis

Run by ENIKAM d.o.o. · NCT07257887 · Data updated 2026-11-12

This trial will test whether using OROXID oral solutions (forte or sensitive) alongside regular dental cleaning helps adults with Stage III, Grade B periodontitis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorENIKAM d.o.o.
Industry-sponsored
Locations2 sites (Ljubljana and 1 other locations)
StatusRecruiting
StartedNovember 19, 2025
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedDecember 2, 2025
Trial IDNCT07257887 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are systemically healthy adults (18+) with generalized Stage III, Grade B periodontitis who have at least three pockets >5 mm and at least 16 natural teeth and who can follow oral hygiene instructions.

Probably not a fit

People with Stage IV periodontitis, recent periodontal treatment or antibiotic use, significant systemic diseases (e.g., diabetes, HIV, liver or kidney disease), or on certain cardiovascular medications are unlikely to qualify or benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with generalized Stage III, Grade B periodontitis will be assigned to receive either OROXID forte oral solution, OROXID sensitive oral solution, or standard of care as an adjunct to routine mechanical periodontal therapy. The study will monitor clinical periodontal measures (such as pocket depth and attachment levels) and record any adverse effects related to the mouth rinses. Participants must be systemically healthy, have at least 16 natural teeth, and present multiple pockets deeper than 5 mm. The trial aims to collect safety and efficacy data on topical hydrogen peroxide–based oral solutions as an adjunct to mechanical plaque control.

Why it matters

Potential benefit: If successful, OROXID could reduce pocket depths and bacterial biofilm activity, helping slow disease progression and potentially preserve teeth with a non‑invasive adjunct.

How similar studies have gone: Hydrogen peroxide and antiseptic mouth rinses have shown modest benefits for plaque and gingivitis in prior studies, but high‑quality evidence for improving established periodontitis outcomes is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Systemically healthy participants aged 18 years or older.
2. Generalized periodontitis, Stage III, Grade B.
3. Presence of three or more periodontal pockets deeper than 5 mm.
4. At least 16 natural teeth (excluding wisdom teeth).
5. Ability to comply with oral hygiene instructions following the intervention.
6. Signed informed consent form after being fully informed about the study.

Exclusion Criteria:

1. Periodontal treatment within the past six months.
2. Dental procedures (surgery, professional cleaning, scaling and root planing, laser therapy, piezotome) within the past six months.
3. Periodontitis, Stage IV.
4. Use of mouth rinses or oral gels within the past month.
5. Use of antibiotic therapy within the past three months.
6. Ongoing therapy with antihypertensives, antilipemics, antiarrhythmics, or other cardiovascular medications.
7. Systemic diseases such as diabetes, HIV/AIDS, liver diseases, chronic kidney disease, tuberculosis, and autoimmune disorders (e.g., lupus, scleroderma, Crohn's disease).
8. History of cardiovascular diseases, including acute myocardial infarction, angina pectoris, heart failure, atrial fibrillation, atrioventricular block, peripheral artery disease, or stroke.
9. Therapy with immunosuppressive agents.
10. Allergy to any ingredients of the study products.
11. Pregnant or breastfeeding women.

Where it's running

  • Klinika Križaj Ljubljana
    Ljubljana, Slovenia
    Recruiting
  • Ustna medicina d.o.o.
    Ljubljana, Slovenia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.